Daxor Announces a Union Hospital Purchase and a Separate Trial of Blood Volume Analyzer BVA-100

SOURCE:

Daxor Corp.

2008-08-13 07:30:00

NEW YORK, NY–(EMWNews – August 13, 2008) – Daxor Corporation (AMEX: DXR), a medical

instrumentation and biotechnology company, today announced a purchase by

Union Hospital and a separate trial agreement for the Blood Volume Analyzer

BVA-100.

The purchase of the BVA-100 was received from Union Hospital of Elkton,

Maryland. Since 1908, Union Hospital has provided quality health and

wellness services to residents in Maryland, Delaware and Pennsylvania. As

a 126-bed state-of-the-art not-for-profit hospital, Union Hospital is the

leading provider in the areas of inpatient, outpatient and emergency

services. With a comprehensive health education program, a team that

includes about 260 physicians and 900 staff members, the recent addition of

its new inpatient tower, renovations to the pediatric unit and an expanded

intensive care unit for patients needing specialized care, Union Hospital

continues to demonstrate its commitment to ensuring high quality

state-of-the-art health care.

The trial agreement for a BVA-100 was received from a 961-bed major medical

center located in Winston-Salem, North Carolina. The trial was arranged to

allow for a 90-day evaluation period of the BVA-100 to demonstrate the

clinical benefit of a measured blood volume in various disease states and

medical conditions. The trial also allows for the facility’s nuclear

medicine department to monitor the increase in patient referrals for a test

that has recently been featured in peer-reviewed medical journals as an

exciting new diagnostic test that can only be performed by nuclear medicine

professionals and provides an evidenced-based approach to treating patients

with hard to diagnose blood volume abnormalities.

Daxor’s Blood Volume Analyzer BVA-100 is the only FDA approved diagnostic

device which provides for a 98% accurate measurement of blood volume.

Daxor Corporation manufactures and markets the BVA-100, a semi-automated

Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex,

Daxor’s single use diagnostic kit. For more information regarding Daxor

Corporation’s Blood Volume Analyzer BVA-100, visit Daxor’s website

www.Daxor.com.

Contact Information:

Stephen Feldschuh
Chief Operating Officer
212-330-8515

or

Diane Meegan
Investor Relations
212-330-8512

free cash grants, free grant money, free money, cash grants, scholarships, business grants, foundation grants, government grants, debt grants, consolidation, college tuition, financial aid, medical grants, personal grants, medical bills, unsecured loans, no interest loans, financing, loans, capital, non profit organizations

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions